Your browser doesn't support javascript.
loading
Personalized treatment of women with early breast cancer: a risk-group specific cost-effectiveness analysis of adjuvant chemotherapy accounting for companion prognostic tests OncotypeDX and Adjuvant!Online.
Jahn, Beate; Rochau, Ursula; Kurzthaler, Christina; Hubalek, Michael; Miksad, Rebecca; Sroczynski, Gaby; Paulden, Mike; Bundo, Marvin; Stenehjem, David; Brixner, Diana; Krahn, Murray; Siebert, Uwe.
Afiliação
  • Jahn B; Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics and Technology, Eduard-Wallnöfer-Zentrum 1, A-6060, Hall i.T, Austr
  • Rochau U; Division of Public Health Decision Modelling, Health Technology Assessment and Health Economics, ONCOTYROL - Center for Personalized Cancer Medicine, Karl-Kapferer-Straße 5, A-6020, Innsbruck, Austria.
  • Kurzthaler C; Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics and Technology, Eduard-Wallnöfer-Zentrum 1, A-6060, Hall i.T, Austr
  • Hubalek M; Division of Public Health Decision Modelling, Health Technology Assessment and Health Economics, ONCOTYROL - Center for Personalized Cancer Medicine, Karl-Kapferer-Straße 5, A-6020, Innsbruck, Austria.
  • Miksad R; Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics and Technology, Eduard-Wallnöfer-Zentrum 1, A-6060, Hall i.T, Austr
  • Sroczynski G; Division of Public Health Decision Modelling, Health Technology Assessment and Health Economics, ONCOTYROL - Center for Personalized Cancer Medicine, Karl-Kapferer-Straße 5, A-6020, Innsbruck, Austria.
  • Paulden M; Institut für Theoretische Physik, Universität Innsbruck, Technikerstraße 21A, A-6020, Innsbruck, Austria.
  • Bundo M; Department of Obstetrics and Gynecology, Medical University of Innsbruck, Christoph-Probst-Platz, Innrain 52, A-6020, Innsbruck, Austria.
  • Stenehjem D; Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave, Boston, 02215, MA, USA.
  • Brixner D; Institute for Technology Assessment and Department of Radiology, Massachusetts General Hospital, Harvard Medical School, 101 Merrimac St., 10th FL, Boston, MA, 02114, USA.
  • Krahn M; Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics and Technology, Eduard-Wallnöfer-Zentrum 1, A-6060, Hall i.T, Austr
  • Siebert U; Division of Public Health Decision Modelling, Health Technology Assessment and Health Economics, ONCOTYROL - Center for Personalized Cancer Medicine, Karl-Kapferer-Straße 5, A-6020, Innsbruck, Austria.
BMC Cancer ; 17(1): 685, 2017 Oct 16.
Article em En | MEDLINE | ID: mdl-29037213
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Análise Custo-Benefício / Recidiva Local de Neoplasia Tipo de estudo: Etiology_studies / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Limite: Female / Humans País/Região como assunto: Europa Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Análise Custo-Benefício / Recidiva Local de Neoplasia Tipo de estudo: Etiology_studies / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Limite: Female / Humans País/Região como assunto: Europa Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article